FDA Rejects Schizophrenia Drug Cariprazine

The FDA has rejected a new drug application for cariprazine , an atypical antipsychotic for the treatment of schizophrenia and for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.

http://www.pharmscope.com/news/DailyDetail.cfm?chosen=68040